Treatment outcome of continuation of intravenous amikacin for Mycobacterium abscessus pulmonary disease with a persistent culture positivity after the treatment initiation.
J Infect Chemother
; 28(8): 1098-1104, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35461769
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mycobacterium abscessus
/
Lung Diseases
/
Mycobacterium Infections, Nontuberculous
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
J Infect Chemother
Journal subject:
MICROBIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2022
Type:
Article
Affiliation country:
South Korea